Research programme: siderophore acylaminopenicillins - Grunenthal/Hans Knoll Institute

Drug Profile

Research programme: siderophore acylaminopenicillins - Grunenthal/Hans Knoll Institute

Alternative Names: HKI 9924067; HKI 9924109; HKI 9924129; HKI 9924154; HKI 9924155; Siderophore acylaminopenicillins - Grunenthal/Hans Knoll Institute

Latest Information Update: 05 Mar 2006

Price : $50

At a glance

  • Originator Grunenthal; Hans Knoll Institute for Natural Products Research
  • Class Penicillins
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • On Fast track

    Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.


Highest Development Phases

  • Preclinical Gram-negative infections

Most Recent Events

  • 11 Jan 2002 Preclinical development for Gram-negative infections in Germany (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top